Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease



: Joutsa J, Martikainen K, Vahlberg T, Kaasinen V

Publisher: ELSEVIER SCI LTD

: 2012

: Parkinsonism and Related Disorders

: PARKINSONISM & RELATED DISORDERS

: PARKINSONISM RELAT D

: 10

: 18

: 10

: 1079

: 1083

: 5

: 1353-8020

DOI: https://doi.org/10.1016/j.parkreldis.2012.06.005


Conclusions: The results suggest that dopamine agonist dose and gender are associated with the prognosis of impulse control disorders. Symptoms of depression emerge together with novel impulse control disorders in Parkinson's disease. (c) 2012 Elsevier Ltd. All rights reserved.



Last updated on 2024-26-11 at 12:35